Company Overview and News
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including United Parcel Service (UPS), Merck (MRK) and BHP Billiton (BHP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
LMT UPS BLT PH BHPBF PCAR CHTR ETP BHP BBL BHP BHPLF
Infrastructure bottlenecks in the Permian Basin, which stemmed from takeaway capacity constraints, is suffocating producers in the region for a long time now. Rising upstream activities in the region have outrun transportation capacity, which forced producers to sell their products at a discounted rate, trimming their profit levels. The extent of discount at the beginning of the year was $3.40 per barrel, which grew to $15.
ETP APA NBL MMP PAA FANG
As per North Dakota’s oil regulator, the state’s daily crude output rose 1.7% in August after increasing 3.4% in the previous month. The North Dakota Department of Mineral Resources’ (‘DMR’) latest data said that oil production in August averaged a record 1,291,496 barrels a day, up 22,206 barrels a day from July.
ENBBF WLL PSX CTLR MALRY ENB ISRG MPC MIN NSC ENB ETP OAS FFIV EBBNF CLR MALRF
Oct 15 (Reuters) - Energy Transfer Partners LP said on Monday that a West Texas pipeline would resume operations on Saturday as planned after the pipeline spilled water with nontoxic green dye and residual crude oil near Abilene, Texas.
(Reuters) - Energy Transfer Partners LP said on Monday that a West Texas pipeline would resume operations on Saturday as planned after the pipeline spilled water with nontoxic green dye and residual crude oil near Abilene, Texas.
2018-10-11 seekingalpha - 1
Energy equities with over .05% Broker Target Upsides showed midstream firms top on the list, Sanchez for price gains and American Midstream for dividend yield, as of 10/8/18.
NGL AMID SNP MMLP SMLP BPL CCLP ETP SNP USAC GPP CVRR SNMP
As we say goodbye to a strong Q3, it’s time to welcome the seasonally strong Q4. So far, the quarter has had a choppy start, with shares pulling back on rising Treasury interest rates. But don’t let that faze you. “The market is going to be on the defensive for another few weeks, but we think it sets up the year-end rally,” Wall Street’s Jeff Saut, chief strategist at Raymond James told CNBC.
ETP ALXN ETE CXO NFLX CI BA RYTM CRM ESRX
2018-10-07 seekingalpha - 2
With one quarter left to go in 2018, there are three things on investors' minds: the Fed, the coming mid-term elections, and the ongoing trade war. Thus far, the market has mostly shrugged off these concerns, though income-focused investments such as bonds, REITs and dividend-paying stocks have had a hard time gaining traction.
FB F ARCC TM ETE NFLX EPD GOOG VLKAF ARU ETP AMZN MIC GOOGL AAPL GM
BISMARCK, N.D. (AP) — A federal judge's decision on whether a year's worth of additional study of the $3.8 billion Dakota Access oil pipeline adequately addresses American Indian concerns appears weeks if not months away.
Investors in Energy Transfer Partners, L.P. (ETP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 18, 2019 $37.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
HOUSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of September 30, 2018.
KMF ETP EBGUF KFM EEP SEP
HOUSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Kayne Anderson MLP/Midstream Investment Company (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of September 30, 2018.
Investors with an interest in Oil and Gas - Production Pipeline - MLB stocks have likely encountered both Energy Transfer Partners, L.P. (ETP - Free Report) and Crestwood Equity Partners LP (CEQP - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
2454 ETP CEQP
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to ETP / Energy Transfer Partners, L.P. on message board site Silicon Investor.
as of ET